Home › NDC Lookup › RxCUI directory › RxCUI 309048

Cefadroxil 50 MG/ML Oral Suspension — RxCUI 309048

RxNorm drug concept · Semantic clinical drug
RxCUI 309048 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 15 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI309048
Official nameCefadroxil 50 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascefadroxil 250 MG per 5 ML Powder for Oral Suspension; cefadroxil 250 MG in 5 mL Oral Suspension; cefadroxil (as cefadroxil monohydrate) 50 MG/ML Oral Suspension
FDA products mapped8
Package NDCs mapped15
Reported Medicaid activity (SDUD)47,623 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cefadroxil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Cefadroxil is used to treat three main types of bacterial infections: urinary tract infections (UTIs), skin and skin structure infections, and strep throat or tonsillitis caused by...
  • What kind of infections does cefadroxil actually treat?
  • You can take it with or without food — it's absorbed fine either way. That said, if you notice any nausea or stomach upset, taking it with a meal or snack can help settle things do...
  • This is really important to flag with your doctor before you start. Cefadroxil and penicillin belong to related antibiotic families, and up to about 1 in 10 people with a penicilli...
📖 Read our full Cefadroxil guide →

🕸️ Concept Web — How Cefadroxil 50 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cefadroxil 50 MG/ML Oral Suspension RxCUI 309048

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cefadroxil 2177
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cefadroxil Oral Suspension 371318
    • Cefadroxil Oral Liquid Product 1152087
    • Cefadroxil Oral Product 1152088
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cefadroxil 50 MG/ML 315592

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cefadroxil 50 MG/ML SCDC · 315592
  • Cefadroxil Oral Suspension SCDF · 371318
  • Cefadroxil Oral Liquid Product SCDG · 1152087
  • Cefadroxil Oral Product SCDG · 1152088

📦 FDA Products & Package NDCs

8 products · 15 package NDCs
15 package NDCs map to RxCUI 309048 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
16714-0389-01 100 mL in 1 BOTTLE (16714-389-01) Cefadroxil NorthStar Rx LLC 2013-04-25
16714-0390-01 75 mL in 1 BOTTLE (16714-390-01) Cefadroxil NorthStar Rx LLC 2013-04-25
16714-0390-02 100 mL in 1 BOTTLE (16714-390-02) Cefadroxil NorthStar Rx LLC 2013-04-25
57237-0097-01 100 mL in 1 BOTTLE (57237-097-01) Cefadroxil Rising Pharma Holdings, Inc. 2013-04-25
57237-0097-50 50 mL in 1 BOTTLE (57237-097-50) Cefadroxil Rising Pharma Holdings, Inc. 2013-04-25
57237-0098-01 100 mL in 1 BOTTLE (57237-098-01) Cefadroxil Rising Pharma Holdings, Inc. 2013-04-25
57237-0098-75 75 mL in 1 BOTTLE (57237-098-75) Cefadroxil Rising Pharma Holdings, Inc. 2013-04-25
65862-0083-01 100 mL in 1 BOTTLE (65862-083-01) Cefadroxil Aurobindo Pharma Limited 2013-04-25
65862-0083-50 50 mL in 1 BOTTLE (65862-083-50) Cefadroxil Aurobindo Pharma Limited 2013-04-25
65862-0084-01 100 mL in 1 BOTTLE (65862-084-01) Cefadroxil Aurobindo Pharma Limited 2013-04-25
65862-0084-50 50 mL in 1 BOTTLE (65862-084-50) Cefadroxil Aurobindo Pharma Limited 2013-04-25
65862-0084-75 75 mL in 1 BOTTLE (65862-084-75) Cefadroxil Aurobindo Pharma Limited 2013-04-25
68180-0181-02 100 mL in 1 BOTTLE (68180-181-02) Cefadroxil Lupin Pharmaceuticals, Inc. 2008-04-23
68180-0182-02 75 mL in 1 BOTTLE (68180-182-02) Cefadroxil Lupin Pharmaceuticals, Inc. 2008-04-23
68180-0182-03 100 mL in 1 BOTTLE (68180-182-03) Cefadroxil Lupin Pharmaceuticals, Inc. 2008-04-23
Observed labelers: Aurobindo Pharma Limited (5) · Rising Pharma Holdings, Inc. (4) · Lupin Pharmaceuticals, Inc. (3) · NorthStar Rx LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.